Premium
Front Cover: A Novel Class of N ‐Sulfonyl and N ‐Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer Cells (ChemMedChem 23/2019)
Author(s) -
Yong Cassandra,
Devine Shane M.,
Gao Xuexin,
Yan Angelina,
Callaghan Richard,
Capuano Ben,
Scammells Peter J.
Publication year - 2019
Publication title -
chemmedchem
Language(s) - English
Resource type - Reports
SCImago Journal Rank - 0.817
H-Index - 100
eISSN - 1860-7187
pISSN - 1860-7179
DOI - 10.1002/cmdc.201900651
Subject(s) - noscapine , chemistry , sulfonyl , natural product , papaver , efflux , opium poppy , potency , stereochemistry , pharmacology , biochemistry , biology , alkaloid , botany , in vitro , alkyl , organic chemistry
The Front Cover shows the natural product noscapine, which is produced by the opium poppy, Papaver somniferum . Noscapine has been used as an antitussive agent since the 1950s, but its anticancer properties and ability to inhibit tubulin polymerisation were not appreciated until the late 1990s. A number of N ‐sulfonyl and N ‐sulfamoyl noscapine derivatives have been identified with improved antiproliferative potency against various cancer cell lines (MCF‐7, PANC‐1, MDA‐MB‐435, and SK‐MEL‐5 cells). These antiproliferative effects were also maintained against drug‐resistant NCI/Adr RES cells despite their high expression of the multidrug efflux pump, P‐glycoprotein. More information can be found in the Full Paper by Peter J. Scammells et al. (DOI: 10.1002/cmdc.201900477) on page 1968 in Issue 23, 2019 , (Photos from iStock/Getty Images by Dr Microbe & mafoto).